Triptorelin Market, By Product (Triptorelin Pamoate, Triptorelin Acetate, Triptorelin Embonate ), By Application (Prostate Cancer, Radical Prostatectomy, Endometriosis, Salivary Gland Cancer, Central Precocious Puberty), By End User ( Hospitals Pharmacy, Retail Pharmacies, Online Pharmacy), and By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and the Rest of the World) – Market Size & Forecasting (2017-2028)

The Global Triptorelin Market size is expected to reach USD 724.4 million by 2028 and is anticipated to grow at a CAGR of 5.6% during the forecast period. Triptorelin is a peptide formulation for injection that was developed mainly for the treatment of advanced metastatic prostate cancer. Furthermore, different indications developed subsequently include the treatment of uterine fibroids a tumor of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine organ wall outside the reproductive tract prior to surgery or when surgery is not deemed appropriate, as well as early-onset puberty and female infertility (in vitro fertilization). Other modalities of triptorelin like triptorelin acetate, triptorelin pamoate, and triptorelin embonate are also used for prostate cancer treatment.

Triptorelin Market Stats

Triptorelin Market Statistics

Triptorelin is extensively used in the palliative treatment of hormone-dependent advanced prostate cancer. Triptorelin market is expected to witness lucrative growth opportunities throughout the forecast period, due to the increasing incidence of prostate cancer and salivary gland cancer and increasing prevalence of central precocious puberty among young patients below age eight and 9 years, worldwide. According to this new indication, Decapeptyl (triptorelin) are used as adjuvant treatment together with tamoxifen or an aromatase inhibitor for endocrine-responsive early-stage breast cancer in women at high risk of recurrence World Health Organization are confirmed as pre-menopausal after completion of chemotherapy. This would enhance the revenue for growth for the triptorelin market, throughout the forecast period. Furthermore, higher efficacy and tolerability of triptorelin in the suppression of gonadotropin secretion in prostate cancer and precocious puberty is increasing the adoption of triptorelin in the market.

Key Factors Impacting the Growth of Triptorelin Market:

  • Increasing research and development in triptorelin for applications in various therapeutic indications, by private makers and research organizations.
  • Currently, various clinical trials are undergoing to expand the potential future application of triptorelin in breast cancer and Human immunodeficiency virus (HIV).

The global triptorelin market segmentation is based on product, application, end user, and region.

Product Outlook:

Based on the product the market is divided into triptorelin pamoate, triptorelin acetate, and triptorelin embonate. The triptorelin pamoate segment is going to dominate the market due to Triptorelin pamoate may cause a short-term (within first 2 weeks of treatment) boom in testosterone serum levels. When this is used for prostate most cancers the resulting "tumor flare" can purpose temporary growth of bone pain, swelling of the prostate that blocks urine flow or swelling around the tumor in the backbone inflicting compression of the spinal cord.

Triptorelin Market Segments

Triptorelin Market Segmentation

Application Outlook

Based on the application the market is divided into prostate cancer, radical prostatectomy, endometriosis, salivary gland cancer, central precocious puberty. The prostate segment is expected to dominate the market during the forecast period owing to the prostate cancer is the second most commonly occurring cancer in men and the fourth most commonly occurring cancer overall.

End User Outlook

Based on the end user the market is segmented into hospitals pharmacy, retail pharmacies, and online pharmacy. The hospital pharmacy end user segment is accounted for the highest market share in the market over the forecast period due to improvements in practice with regard to pre-treatment considerations and appropriate monitoring during therapy.

Triptorelin Market Region

Triptorelin Market Regional Analysis

Regional Outlook:

Based on the region, the global triptorelin market has been segmented by North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, & Rest of the World. In terms of revenue, North America holds a dominant position in the global triptorelin market in 2018. The region's dominance is attributable to due to growing prevalence of prostate cancer and the salivary gland most cancers and growing incidence of crucial precocious puberty among young patients below age eight and 9 years, worldwide and increasing changes in the lifestyle of people, their eating habits, etc.

Competitive Landscape

The key leading players in the market include Ipsen, Bachem, Ferring Pharmaceuticals Pvt Ltd., Chengdu Tiantaishan Pharmaceutical Co., Ltd., Tecnofarma, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.), Debiopharm Group, and Arbor Pharmaceuticals, LLC.

This report also includes the profiles of key Triptorelin market companies along with their SWOT analysis and market strategies. In addition, these competitive landscapes provide a detailed description of each company including future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launch, new product developments, and other latest industrial developments.

Key Developments in Triptorelin Market:

  • For instance, according to National Organization for Rare Disorders (NORD), 2016 data findings, Central Precocious Puberty (CPP), accounting for 1 to 5 in 10,000 children with a female to male ratio of about 20:1, in the U.S.
  • In March 2017, Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK, in coordination with fourteen other European regulatory agencies approved a new indication of Decapeptyl (triptorelin).
  • In 2016, the collaboration of the European Organization for Research and Treatment of Cancer with Debiopharm International SA to investigate Triptorelin for treatment of salivary gland cancer.
  • In 2017 triptorelin got approved as an adjuvant treatment in combination with tamoxifen or an aromatase inhibitor for endocrine-responsive early stage breast cancer in the women at high risk of recurrence for those are confirmed as pre-menopausal after completion of chemotherapy.

Triptorelin Market

Triptorelin Market Timeline (2017-2028)

What Does This Report Provide?

This report provides a detailed understanding of the global triptorelin market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

By Product

  • Triptorelin Pamoate
  • Triptorelin Acetate
  • Triptorelin Embonate

By Application

  • Prostate Cancer
  • Radical Prostatectomy
  • Endometriosis
  • Salivary Gland Cancer
  • Central Precocious Puberty

By End User

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Component
    • By Mode of Delivery
    • By End User
  • Western Europe
    • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
    • By Component
    • By Mode of Delivery
    • By End User
  • Eastern Europe
    • By Country (Russia, Turkey, Rest of Eastern Europe)
    • By Component
    • By Mode of Delivery
    • By End User
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Component
    • By Mode of Delivery
    • By End User
  • Middle East
    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
    • By Component
    • By Mode of Delivery
    • By End User
  • Rest of the World
    • By Region (South America, Africa)
    • By Component
    • By Mode of Delivery
    • By End User

Reasons to Buy This Report:

  • Market size estimation of the population health management market on a regional and global basis
  • Unique research Usage for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: sales@quincemarketinsights.com